Allakos Inc (ALLK) has released an update to notify the public and investors about a regulation fd disclosure.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Craig Paterson, M.D. announced his retirement as Chief Medical Officer of Allakos Inc., effective February 9, 2024, without disagreements with the company. Chin Lee, M.D., M.P.H., with over 17 years of experience and a strong background in clinical research and development, will succeed him. Dr. Lee, who has held significant roles in various biopharmaceutical companies including Genentech and Eli Lilly, will bring his expertise in global regulatory filings and product commercialization to his new role at Allakos.
For further insights into ALLK stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.